← Back to Clinical Trials
Recruiting NCT05940350

NCT05940350 Telerehabilitation-Based Coaching Interventions (TeleSCoP) for Patients With Ischemic Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05940350
Status Recruiting
Phase
Sponsor Akdeniz University
Condition Ischemic Stroke
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-02-01
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Telerehabilitation Stroke Coaching of Program (TeleSCoP) group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-02-01 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Ischemic stroke has high morbidity and mortality worldwide. Stroke patients experience physical, psychological, and social problems, and require rehabilitation. The aim of stroke rehabilitation is to support patients in optimizing their physical, functional, mental, social, and occupational aspects. Telerehabilitation-based coaching interventions are among the individualized interventions applied to patients. This study aimed to examine the effects of telerehabilitation-based coaching interventions on self-efficacy, modifiable risk factors, and repeated hospitalizations in patients with ischemic stroke. It is predicted that discharge education in disease management and telerehabilitation-based coaching interventions will increase self-efficacy, reduce modifiable risk factors (blood pressure, cholesterol, triglyceride, HbA1c levels, body mass index, smoking, and alcohol use), and reduce repeated hospitalizations. With an education booklet prepared for ischemic stroke patients and primary care providers, one-on-one face-to-face education is planned while patients are in the clinic on the fourth or fifth day of stroke. Determination of individual goals with motivational interview, sending educational videos prepared in cooperation with the multidisciplinary health team to the phones or e-mails of the patients, providing telerehabilitation-based coaching a total of seven times for three months after discharge, monitoring the targets set weekly and monthly, and monthly follow-up after three months. It is planned to support patients with practices such as achieving their goals, maintaining healthy lifestyle changes such as diet and physical activity, and monitoring metabolic parameters. The evaluation form of the education booklet, videos prepared with the cooperation of the multidisciplinary team, and phone call evaluation form will be evaluated by 10 experts. The preliminary application will be tested with 6 patients, and the final form will be provided. The second phase of the study was designed as a single-center, single-blind (participant), randomized controlled study. The study will be carried out with a total of 60 patients with ischemic stroke, 30 in the intervention group and 30 in the control group, who continued to be followed up and treated at the Neurology Clinic of Akdeniz University Hospital.

Eligibility Criteria

Inclusion Criteria: * Patients aged 45 years and older who had a stroke (the etiology of ischemic stroke can be seen at an earlier age due to hematological conditions, such as sickle cell anemia, polycythemia vera, factor deficiencies, vasculitis, and arterial dissection). * Comply with TOAST classification criteria * A score of "0,1,2,3" according to the Modified Rankin Scale at discharge * Place, time, person orientation * No communication barrier * Turkish-speaking writer * Having a contact phone (for phone calls) * Support can be obtained from first-degree situations) * Having no barriers to answering questions physically and mentally Exclusion Criteria: * Stroke of cryptogenic (etiology unknown) or non-vascular origin (tumor) * Have a diagnosed mental or psychiatric illness\* * With dementia and cognitive deficit\* * Clinically musculoskeletal or other neurological diseases\* * With severe aphasia and dysarthria\* * With terminal illness\* * Those who score ≥ 10 according to the LACE index * Patients whose information cannot be accessed will not be included in the study.

Contact & Investigator

Central Contact

Kamile Topcu, MSc

✉ kamile-m@hotmail.com

📞 +905418651989

Principal Investigator

Hicran Bektas, PhD, RN

PRINCIPAL INVESTIGATOR

Akdeniz University

Frequently Asked Questions

Who can join the NCT05940350 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05940350 currently recruiting?

Yes, NCT05940350 is actively recruiting participants. Contact the research team at kamile-m@hotmail.com for enrollment information.

Where is the NCT05940350 trial being conducted?

This trial is being conducted at Antalya, Turkey (Türkiye).

Who is sponsoring the NCT05940350 clinical trial?

NCT05940350 is sponsored by Akdeniz University. The principal investigator is Hicran Bektas, PhD, RN at Akdeniz University. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology